SEC Form 4 · accession 0001179110-15-002007

ABBOTT LABORATORIES · ABT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

John M Capek

Officer — Executive Vice President

Period of report

Feb 4, 2015

Accepted (ET)

Feb 6, 2015 · 5:11 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000001800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common shares without par value	Feb 4, 2015	M	83,000	$25.2461	A	309,945	D
Common shares without par value	Feb 4, 2015	S	100	$45.57	D	309,845	D
Common shares without par value	Feb 4, 2015	S	100	$45.5775	D	309,745	D
Common shares without par value	Feb 4, 2015	S	1,400	$45.58	D	308,345	D
Common shares without par value	Feb 4, 2015	S	1,600	$45.59	D	306,745	D
Common shares without par value	Feb 4, 2015	S	200	$45.595	D	306,545	D
Common shares without par value	Feb 4, 2015	S	2,300	$45.60	D	304,245	D
Common shares without par value	Feb 4, 2015	S	400	$45.605	D	303,845	D
Common shares without par value	Feb 4, 2015	S	1,300	$45.61	D	302,545	D
Common shares without par value	Feb 4, 2015	S	805	$45.62	D	301,740	D
Common shares without par value	Feb 4, 2015	S	300	$45.625	D	301,440	D
Common shares without par value	Feb 4, 2015	S	700	$45.63	D	300,740	D
Common shares without par value	Feb 4, 2015	S	1,700	$45.64	D	299,040	D
Common shares without par value	Feb 4, 2015	S	200	$45.645	D	298,840	D
Common shares without par value	Feb 4, 2015	S	2,700	$45.65	D	296,140	D
Common shares without par value	Feb 4, 2015	S	500	$45.655	D	295,640	D
Common shares without par value	Feb 4, 2015	S	100	$45.6575	D	295,540	D
Common shares without par value	Feb 4, 2015	S	3,987	$45.66	D	291,553	D
Common shares without par value	Feb 4, 2015	S	700	$45.665	D	290,853	D
Common shares without par value	Feb 4, 2015	S	2,500	$45.67	D	288,353	D
Common shares without par value	Feb 4, 2015	S	900	$45.675	D	287,453	D
Common shares without par value	Feb 4, 2015	S	100	$45.6775	D	287,353	D
Common shares without par value	Feb 4, 2015	S	2,700	$45.68	D	284,653	D
Common shares without par value	Feb 4, 2015	S	600	$45.685	D	284,053	D
Common shares without par value	Feb 4, 2015	S	100	$45.6875	D	283,953	D
Common shares without par value	Feb 4, 2015	S	2,600	$45.69	D	281,353	D
Common shares without par value	Feb 4, 2015	S	100	$45.695	D	281,253	D
Common shares without par value	Feb 4, 2015	S	2,500	$45.70	D	278,753	D
Common shares without par value	Feb 4, 2015	S	600	$45.705	D	278,153	D
Common shares without par value	Feb 4, 2015	S	2,500	$45.71	D	275,653	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F1	$25.2461	Feb 4, 2015	M	83,000	D	Feb 16, 2010	Feb 15, 2017	Common shares	83,000	0	D

Explanation of responses

F1Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Form 1 of 3.